Dyad Medical's Echo:Prio echocardiography image analysis software has secured U.S. Food and Drug Administration (FDA) 510(k) clearance.
Available on the firm's Libby cloud- and artificial intelligence (AI)-based cardiac imaging analysis platform, Echo:Prio analyzes echocardiography images and serves as a decision-making support tool for index quantification of cardiac function, according to the vendor.
It can be used from any location on any device and to provide an immediately available second opinion during interpretation, according to Dyad.